Literature DB >> 25892346

Gastrojejunostomy stricture rate: comparison between antecolic and retrocolic laparoscopic Roux-en-Y gastric bypass.

Lara Ribeiro-Parenti1, Konstantinos Arapis2, Denis Chosidow2, Jean-Loup Dumont3, Monique Demetriou4, Jean-Pierre Marmuse2.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass procedure is an effective treatment for morbid obesity. One of the most frequent complications after this operation is the appearance of a gastrojejunal anastomotic stricture. Mechanisms underlying the development of such complication are unclear.
OBJECTIVE: The aim of the present retrospective study was to compare the rates of gastrojejunostomy stricture between the antecolic and retrocolic technique in a large cohort of patients undergoing Roux-en-Y gastric bypass for morbid obesity, with the same gastrojejunal anastomotic technique.
SETTING: University Hospital, France.
METHODS: From November 2000 to March 2012, 1500 patients underwent laparoscopic Roux-en-Y gastric bypass. The antecolic and the retrocolic technique were used in respectively 572 and 928 consecutive patients. All procedures were performed using a circular stapled gastrojejunostomy and absorbable sutures.
RESULTS: There was no significant difference with respect to gender, age, body mass index, and obesity related co-morbidities between both groups. Patients were followed for 24-146 months (mean 67.5 mo). Fifty-one patients developed a gastrojejunal stricture (3.4%), 37 in the antecolic group (6.5%) and 14 in the retrocolic group (1.5%). The difference was significant (P< .0001). The mean time to onset of gastrojejunal stricture symptoms after surgery was 1 month, ranging from 1 to 3 months. All patients were successfully treated using Savary-Gilliard dilatators. All patients with a gastrojejunal stricture were followed up for a minimum of 36 months. No recurrence was observed and no revisional surgery was needed. Weight loss was similar in patients who developed an anastomotic stricture compared with those without stricture. In the antecolic group internal hernia occurred in 12 of the 110 with no closure of mesenteric defects and in 8 of the 462 (1.7%) with defects closed. In the retrocolic group, 11 patients (1.2%) developed an internal hernia.
CONCLUSIONS: A significant lower gastrojejunal stricture rate was observed in the retrocolic group, with no increased risk of internal hernia, when mesenteric defects were closed. The antecolic technique seems to be a risk factor for gastrojejunal stricture development after laparoscopic gastric bypass.
Copyright © 2015 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anastomotic complications; Bariatric surgery; Gastric bypass; Gastrojejunal strictures

Mesh:

Year:  2015        PMID: 25892346     DOI: 10.1016/j.soard.2015.01.019

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  4 in total

1.  Safety and Efficacy of Endoscopically Secured Fully Covered Self-Expandable Metallic Stents (FCSEMS) for Post-Bariatric Complex Stenosis.

Authors:  Lea Fayad; Cem Simsek; Roberto Oleas; Yervant Ichkhanian; Georges E Fayad; Saowanee Ngamreungphong; Michael Schweitzer; Andreas Oberbach; Anthony N Kalloo; Mouen A Khashab; Vivek Kumbhari
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

2.  The use of computed tomography in the diagnosis of Petersen's hernia after Billroth II or Roux-en-Y reconstruction for gastric cancer: a description of three cases.

Authors:  Xin Fang; Shuang Li; Fabao Gao; Bing Wu
Journal:  Quant Imaging Med Surg       Date:  2022-07

3.  Anastomotic Strictures After Roux-en-Y Gastric Bypass: a Cohort Study from the Scandinavian Obesity Surgery Registry.

Authors:  Kristina Almby; David Edholm
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

4.  Use of lumen-apposing metal stents (LAMS) in the management of gastro jejunostomy stricture following Roux-en-Y Gastric Bypass for obesity: a prospective series.

Authors:  Adam Peter Skidmore
Journal:  BMC Surg       Date:  2021-07-17       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.